---
title: 'Senior Manager, Medical Communications at IMVT Corporation'
canonical: 'https://feeny.ai/job/senior-manager-medical-communications-imvt-corporation-remote-s03pz93xa8tp'
type: 'job'
last_seen: '2026-10-30'
---

# Senior Manager, Medical Communications at IMVT Corporation

- **Company:** IMVT Corporation
- **Location:** Remote
- **Compensation:** $160k–$180k
- **Work type:** remote
- **Posted:** 2026-10-29
- **Last confirmed live:** 2026-10-30
- **Apply:** https://job-boards.greenhouse.io/imvtcorporation/jobs/6238311004

## Job description

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs.

The Role:

Reporting to the Executive Director, Medical Communications & Operations, this position is responsible for managing the development of scientific content across medical communication activities.

Key Responsibilities:

- Support the development and execution of medical affairs and scientific exchange materials, including medical education, congress content, slide decks, FAQs, training materials, advisory boards and field medical tools
- Partner with medical communications agency to ensure medical materials are developed according to timelines and objectives
- Review, annotate, and proofread materials to check quality and scientific accuracy and to ensure that the content, format, and structure of documents comply with internal standards and policies and external guidelines and requirements
- Monitor deadlines and budget to ensure projects are delivered on time to align with other company-wide projects, within budget and scope
- Identify and secure copyright permission licenses, as necessary
- Participate in MRC review process, as needed
- Contribute to identifying opportunities for innovative and strategic omnichannel medical communication activities, including publication extenders, to enhance HCP engagement and scientific exchange
- Participate in congress planning activities including identifying and securing opportunities and ensuring timelines are met; partner with the clinical development and commercial teams to develop congress materials, identify training needs, and provide coverage support according to key objectives
- Support medical communications planning activities and development and pull-through of the scientific platform and narrative across channels and teams

Requirements:

- Master’s or bachelor’s level degree in science-related fields (e.g., BS, BSN, RPh, PA, NP) required; advanced degree (PharmD, M.D. or Ph.D.) preferred
- 3+ years of medical affairs experience; experience in immunology preferred
- Experience developing medical education materials required
- Experience in medical publications preferred
- Strong working knowledge of review processes and medical content compliance
- A superb command of the English language, both written and spoken; faultless grammar and spelling
- Ability to interpret complex data and articulates information across a variety of tactics
- Demonstrated ability to work with a diverse set of stakeholders on multiple projects

Work Environment:

- Remote-based
- Dynamic, interactive, fast-paced, and entrepreneurial environment
- Domestic or international travel are required (5-20%)

Salary range for posting $160,000—$180,000 USD

Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.

## About IMVT Corporation

## Company Overview
- **One-liner**: A clinical-stage immunology company developing innovative anti-FcRn therapies to enable normal lives for people with autoimmune diseases.
- **Entity Type**: Public (Nasdaq: IMVT)
- **Headquarters**: Durham, North Carolina, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology / Autoimmune disease therapeutics
- **Target customers**: Patients with IgG-mediated autoimmune diseases; healthcare providers; payers (B2B/B2C mix via prescription drugs)
- **Mission or purpose statement**: “Dedicated to enabling normal lives for people with autoimmune diseases” [immunovant.com](https://www.immunovant.com/)

## Products & Services
- **[IMVT-1402 (imeroprubart)]**: A novel, fully human monoclonal antibody that targets FcRn to reduce pathogenic IgG autoantibodies. Designed as a subcutaneous injection with a simple autoinjector (YpsoMate®). In clinical development for six indications: Graves’ disease (GD), difficult-to-treat rheumatoid arthritis (D2T RA), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), Sjögren’s disease (SjD), and cutaneous lupus erythematosus (CLE). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **[Batoclimab (first-generation anti-FcRn)]**: Development discontinued across all indications after Phase 3 TED trials did not meet primary endpoints; learnings inform IMVT-1402 program. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Market Standing
- **Valuation/Market Cap**: Not disclosed in available sources (publicly traded on Nasdaq; refer to real-time market data).
- **Key Metric**: Clinical-stage company with no approved products or revenue; total funding and operating expenses are detailed in SEC filings but not summarized here.
- **Notable Investors/Partners**: HanAll Biopharma (collaboration on anti-FcRn antibodies); Ypsomed AG (auto-injector YpsoMate®). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **Growth Signals**: Six ongoing clinical programs (including potentially registrational trials); deep IgG reductions (~80% with weekly 600 mg IMVT-1402) suggesting best-in-class potential; Phase 1 safety data showing no/minimal albumin reduction or LDL cholesterol increases. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Competitive Advantages
- **Potential best-in-class efficacy**: IMVT-1402 achieves deeper IgG reductions than competitor anti-FcRn antibodies, correlating with improved clinical outcomes.
- **Favorable safety profile**: No or minimal off-target effects on albumin and LDL cholesterol, unlike some FcRn inhibitors.
- **Convenient administration**: Self-administered subcutaneous autoinjector (YpsoMate®) expected at launch, improving patient adherence.
- **Broad pipeline**: Six indications in development across endocrinology, rheumatology, neurology, and dermatology, with potential for more.

## Strategic Focus
- Execute pivotal trials for IMVT-1402 in GD, D2T RA, MG, CIDP, SjD, and CLE.
- Leverage learnings from batoclimab program to accelerate IMVT-1402 development.
- Plan to assess new indications for IMVT-1402 beyond the initial six.
- Continue to build commercial capabilities for eventual launch. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Why Work Here
- **Culture**: Emphasizes “Hire and Retain Only the Very Best,” “One Team, Shared Success,” “Ownership Mentality,” and “Patients Are Waiting” – a mission-driven, high-performance environment. [About Us](https://www.immunovant.com/about-us)
- **Remote/Hybrid Policy**: Job listings show a mix of remote and hybrid roles (e.g., “Remote” for many positions, “Hybrid - NYC” for commercial roles). [Careers](https://www.immunovant.com/join-us/explore-careers)
- **Notable Perks**: Merit-based recognition, focus on impact and results, creative problem-solving encouraged. [About Us](https://www.immunovant.com/about-us)
- **Engineering/Science Culture**: Clinical-stage biotech with cutting-edge FcRn technology; opportunities in clinical development, biometrics, quality assurance, and commercial roles. [Careers](https://www.immunovant.com/join-us/explore-careers)

## Sources
1. [Immunovant Corporate Website](https://www.immunovant.com/)
2. [About Us – Values and Culture](https://www.immunovant.com/about-us)
3. [Company Information – Investor Relations](https://www.immunovant.com/investors/company-information)
4. [Explore Careers – Job Listings](https://www.immunovant.com/join-us/explore-careers)
5. [10-K SEC Filing (May 20, 2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Other roles at IMVT Corporation

- [Associate Director, Biostatistics](https://feeny.ai/job/associate-director-biostatistics-imvt-corporation-remote-dgj2yvz4mm9k)
- [Executive Director, Marketing](https://feeny.ai/job/executive-director-marketing-imvt-corporation-remote-sc5ja0w76sbv)
- [Executive Director, New Product Planning](https://feeny.ai/job/executive-director-new-product-planning-imvt-corporation-remote-hek53s90egtb)
- [Director, Infrastructure & Data Platforms](https://feeny.ai/job/director-infrastructure-data-platforms-imvt-corporation-remote-vcb6ytpndm32)
- [Director, Supply Chain Product Planning](https://feeny.ai/job/director-supply-chain-product-planning-imvt-corporation-remote-a4ek4z6agfre)
- [Senior Director, Corporate & Commercial IT Business Systems](https://feeny.ai/job/senior-director-corporate-commercial-it-business-systems-imvt-corporation-remote-vw2vm2e990w9)
- [Senior Manager, Statistical Programming](https://feeny.ai/job/senior-manager-statistical-programming-imvt-corporation-remote-6q5z9h7nwxvn)
- [Director, Financial Planning & Analysis](https://feeny.ai/job/director-financial-planning-analysis-imvt-corporation-remote-2xtk0zhd4zbr)
- [Executive Assistant](https://feeny.ai/job/executive-assistant-imvt-corporation-new-york-m7dv0wr8rkjs) — New York, NY
- [Director, Medical Science Liaison (MSL)](https://feeny.ai/job/director-medical-science-liaison-msl-imvt-corporation-southeast-cnykwbftkpjw) — Southeast, United States